{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-278858","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.947270+00:00","generated_at":"2026-06-08T01:26:01.779272+00:00","sec_items":["1.01","2.03","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Bellevue Life Sciences SPAC to acquire OSR Holdings Co., Ltd. in share exchange","bullets":["BLAC entered Business Combination Agreement to acquire at least 60% of OSR shares; minimum $5M+ cash in trust condition.","Transaction requires BLAC stockholder approval, HSR clearance, and at least 60% of OSR holders to participate; outside date May 14, 2024.","BLAC issued $180,000 unsecured promissory note to sponsor Bellevue Capital Management; due at closing or Dec 31, 2024.","CEO Kuk Hyoun Hwang serves as CEO of both BLAC and OSR; M&A Committee of independent directors approved deal.","BLAC adopted clawback policy to comply with Nasdaq listing standards under Section 10D of Exchange Act."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-278858","json":"https://secwatch.observer/filing/0001193125-23-278858.json","markdown":"https://secwatch.observer/filing/0001193125-23-278858.md","text":"https://secwatch.observer/filing/0001193125-23-278858.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/d881994d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:26:01.779272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d15419c0555b140920047b78c5d9f6666fad7c7","claim":"OSR Holdings, Inc. incurred loan of $180,000 with Bellevue Capital Management LLC at not interest bearing maturing December 31, 2024 or the date on which BLAC consummates an initial business combination.","evidence_excerpt":"On November 13, 2023, BLAC issued an unsecured promissory note (the “ Promissory Note ”) in the principal amount of $180,000 to Bellevue Capital Management LLC, a Washington limited liability company and the Manager of Bellevue Global Life Sciences Investors, LLC, the Sponsor of BLAC (“BCM”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$180,000"},{"label":"Counterparty","value":"Bellevue Capital Management LLC"},{"label":"Rate","value":"not interest bearing"},{"label":"Maturity","value":"December 31, 2024 or the date on which BLAC consummates an initial business combination"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"3fa6de286d2367cf26d7e519420c287955e3a677","claim":"OSR Holdings, Inc. entered into Business Combination Agreement with Bellevue Life Sciences Acquisition Corp. (effective 2023-11-16).","evidence_excerpt":"On November 16, 2023, Bellevue Life Sciences Acquisition Corp., a Delaware corporation (“ BLAC ”), and OSR Holdings Co., Ltd., a corporation organized under the laws of the Republic of Korea (the “ Company ”), entered into a Business Combination Agreement (the “ Business Combination Agreement ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1840425/000119312523278858/0001193125-23-278858-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Bellevue Life Sciences Acquisition Corp."},{"label":"Effective","value":"2023-11-16"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}